STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 101 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $353,000 | -59.1% | 73,061 | -10.2% | 0.00% | -100.0% |
| Q4 2019 | $864,000 | +159.5% | 81,351 | +154.6% | 0.00% | – |
| Q3 2019 | $333,000 | +17.3% | 31,948 | +72.1% | 0.00% | – |
| Q2 2019 | $284,000 | +6.8% | 18,561 | -9.8% | 0.00% | – |
| Q1 2019 | $266,000 | +100.0% | 20,580 | +46.6% | 0.00% | – |
| Q4 2018 | $133,000 | -81.8% | 14,041 | -69.2% | 0.00% | -100.0% |
| Q2 2018 | $732,000 | +293.5% | 45,598 | +172.1% | 0.00% | – |
| Q3 2017 | $186,000 | +51.2% | 16,756 | +45.9% | 0.00% | – |
| Q4 2016 | $123,000 | +70.8% | 11,483 | +8.7% | 0.00% | – |
| Q2 2016 | $72,000 | -41.9% | 10,567 | +0.2% | 0.00% | – |
| Q2 2015 | $124,000 | -69.5% | 10,545 | -55.7% | 0.00% | – |
| Q4 2014 | $406,000 | +161.9% | 23,809 | +125.5% | 0.00% | – |
| Q2 2014 | $155,000 | -77.5% | 10,557 | -68.8% | 0.00% | -100.0% |
| Q1 2014 | $689,000 | -19.1% | 33,812 | -22.2% | 0.00% | 0.0% |
| Q4 2013 | $852,000 | – | 43,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 220,000 | $9,965,000 | 0.68% |
| Healthcare Value Capital, LLC | 16,464 | $746,000 | 0.65% |
| EAM Investors, LLC | 69,151 | $3,132,000 | 0.62% |
| Baker Brothers Advisors | 800,400 | $36,255,000 | 0.52% |
| Spark Investment Management LLC | 38,300 | $1,733,000 | 0.40% |
| Perceptive Advisors | 180,416 | $8,172,000 | 0.34% |
| SIGMA CAPITAL MANAGEMENT LLC | 175,000 | $7,926,000 | 0.33% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 129,915 | $5,885,000 | 0.23% |
| Visium Asset Management, LP | 150,000 | $6,794,000 | 0.15% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 19,732 | $894,000 | 0.14% |